Where does Ipsen Pharma S.A.S. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Ipsen Pharma S.A.S. ranks #7,718 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Ipsen Pharma S.A.S. hold?

Ipsen Pharma S.A.S. holds 42 US utility patents granted between 2015 and 2023, spanning 14 technology areas.

What is Ipsen Pharma S.A.S.'s Innovation Score?

Ipsen Pharma S.A.S. has an Innovation Score of 40.7 out of 100 (top 35% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Ipsen Pharma S.A.S. focus on?

Ipsen Pharma S.A.S.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 38 patents, ranking #491 of 6,058 assignees active in that subclass. Grants appear in 14 CPC subclasses total.

Is Ipsen Pharma S.A.S.'s patent grant rate increasing or decreasing?

Ipsen Pharma S.A.S.'s recent grant velocity is -89% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Ipsen Pharma S.A.S.'s patents?

Ipsen Pharma S.A.S.'s patents average 16.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Ipsen Pharma S.A.S. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Ipsen Pharma S.A.S.

USPTO PatentsView assignee record - 42 granted patents across 14 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Ipsen ranks #7,718 of 49,997 tracked US assignees by granted-patent volume, with 42 patents across 14 technology areas.

#7,718
of 49,997 US assignees by volume: Top 35%
by Innovation Score (40.7/100): 16.7
avg claims per patent: -89%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7718 · Foreign Corporation #7,718 · 42 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 42 grants
UPPER-Q #7,718/49,997
PHOTO-FINISH Hewlett-Packard…
CPC-FOCUS A61P · 14 areas
INNOV-PAR 40.7/100
CLAIMS-RICH 16.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -89% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Hewlett-Packard Industrial Printing Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Ipsen’s 40.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.0 pts (32%) Velocity 4.4 pts (11%) Breadth 13.2 pts (33%) Claim depth 10.0 pts (25%)

Qualcomm Incorporated · highest

85
Enzo Biochem · near

41
Furcifer · near

41
Horizon International · near

41
Ipsen Pharma S · this assignee

41
Stichting Energieond… · near

41
3D Lighting… · lowest

7

What this shows Ipsen's Innovation Score is 40.7/100 (top 35% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Ipsen?

Each dot is one of Ipsen’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ipsen’s own 16.7 claims/patent is ABOVE the 15.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Ipsen vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Ipsen's grants concentrate

Ipsen Pharma S.A.S. is a focused PatentsView assignee: 14 CPC subclasses with 90.5% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (15 grants) versus a trough of 1 in 2019. By volume, Ipsen sits between Hewlett-Packard Industrial Printing Ltd. and Institute of Rock and Soil Mechanics, Chinese Academy of Sciences.

Ipsen's three-year grant acceleration

Ipsen Pharma S.A.S. shows 2 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Hewlett-packard I…

42
Huawei Duesseldorf

42
Impact Selector I…

42
Inpex

42
Iridium Satellite

42
Incase Designs

42
Inotera Memories

42
Institute of Rock…

42
Ipsen Pharma S ◀

42

What this shows Ipsen holds 42 patents at rank #7,714, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Ipsen

By rank, the assignees closest to #7,714 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Ipsen's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Ipsen, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Ipsen ranks #491 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (41 here).

Horizon International Inc. 41 Enzo Biochem, Inc. 41 Furcifer Inc. 41 Stichting Energieonderzoek Centrum Nederland 41

Ipsen's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 35% higher than 65% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Ipsen Pharma S.A.S. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	15	35.7%
2016	12	28.6%
2017	8	19.0%
2018	2	4.8%
2019	1	2.4%
2020	2	4.8%
2023	2	4.8%

Which technologies does Ipsen Pharma S.A.S. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 38

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 36

C07K - Peptides 23

C07D - Heterocyclic Compounds 6

C07C - Acyclic OR Carbocyclic Compounds 3

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

Y02A - Technologies FOR Adaptation TO Climate Change 1

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 1

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 1

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 1

C12Y - Enzymes 1

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

Top 14 of 14 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Ipsen Pharma S.A.S.'s patent record in context - here's where to go next.

Ipsen Pharma S.A.S.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 90.5% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #7,718 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Ipsen Pharma S.A.S. against Hewlett-Packard Industrial Printing Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.